Broking analysts have lowered their expectations on Cochlear after Friday's disappointing results, but in the main their valuations are above ... Read More The post Health Check: Brokers slash ...

Cochlear reaffirmed guidance for FY 2025 underlying ... Howitt expressed confidence that the new processor would boost upgrades, especially among recipients preferring off-the-ear devices.

DURHAM, N.C., February 14, 2025--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 ...

The company said sales of its cochlear implants were expected to grow around 10 per cent this financial year but services growth had slowed since it launched a new processor model called Nucleus 8.

Technological advancements, such as improved sound processors and minimally invasive implantation procedures, have made cochlear implants more accessible and appealing to adults.

MUSC is leading the country in a clinical trial testing a new cochlear implant.Doctors at MUSC say they are the only site on ...

The Cochlear Ltd (ASX ... The introduction of the new off-the-ear Nucleus Kanso 3 Sound Processor from mid-2025 is expected to contribute to Services revenue from FY26. Acoustics growth rates ...

and an externally worn speech processor. The cochlear implant converts acoustic sound to an electrical signal that can give an individual with significant hearing loss new auditory information to ...

“Lower upgrade rates were experienced for a range of reasons including continuing high satisfaction with the Cochlear Nucleus 7 sound processor.’’ Revenue from new cochlear implants grew 12 ...